These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25413413)

  • 1. Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy: Analysis of a multi-institutional preclinical trial planning study.
    Cui Y; Chen W; Kong FM; Olsen LA; Beatty RE; Maxim PG; Ritter T; Sohn JW; Higgins J; Galvin JM; Xiao Y
    Pract Radiat Oncol; 2015; 5(2):e67-75. PubMed ID: 25413413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer.
    Senan S; van Sörnsen de Koste J; Samson M; Tankink H; Jansen P; Nowak PJ; Krol AD; Schmitz P; Lagerwaard FJ
    Radiother Oncol; 1999 Dec; 53(3):247-55. PubMed ID: 10660205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of peer review of volume delineation in stereotactic body radiation therapy planning for primary lung cancer: a multicenter quality assurance study.
    Lo AC; Liu M; Chan E; Lund C; Truong PT; Loewen S; Cao J; Schellenberg D; Carolan H; Berrang T; Wu J; Berthelet E; Olson R
    J Thorac Oncol; 2014 Apr; 9(4):527-33. PubMed ID: 24736076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of contouring variation with modeled outcome for conformal non-small cell lung cancer radiotherapy.
    Jameson MG; Kumar S; Vinod SK; Metcalfe PE; Holloway LC
    Radiother Oncol; 2014 Sep; 112(3):332-6. PubMed ID: 24853367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of atlas and deep learning based automatic contouring for lung cancer.
    Lustberg T; van Soest J; Gooding M; Peressutti D; Aljabar P; van der Stoep J; van Elmpt W; Dekker A
    Radiother Oncol; 2018 Feb; 126(2):312-317. PubMed ID: 29208513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer.
    Lavrenkov K; Christian JA; Partridge M; Niotsikou E; Cook G; Parker M; Bedford JL; Brada M
    Radiother Oncol; 2007 May; 83(2):156-62. PubMed ID: 17493699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
    van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity modulated radiotherapy of non-small-cell lung cancer incorporating SPECT ventilation imaging.
    Munawar I; Yaremko BP; Craig J; Oliver M; Gaede S; Rodrigues G; Yu E; Reid RH; Leung E; Urbain JL; Chen J; Wong E
    Med Phys; 2010 Apr; 37(4):1863-72. PubMed ID: 20443508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
    Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
    Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the anatomic changes and dosimetric consequences in adaptive CRT of non-small-cell lung cancer using deformable CT and CBCT image registration.
    Ma C; Hou Y; Li H; Li D; Zhang Y; Chen S; Yin Y
    Technol Cancer Res Treat; 2014 Apr; 13(2):95-100. PubMed ID: 23919391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in target volume definition for postoperative radiotherapy in stage III non-small-cell lung cancer: analysis of an international contouring study.
    Spoelstra FO; Senan S; Le Péchoux C; Ishikura S; Casas F; Ball D; Price A; De Ruysscher D; van Sörnsen de Koste JR;
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1106-13. PubMed ID: 19560881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of organ-at-risk contour variations on automatically generated treatment plans for NSCLC.
    Vaassen F; Hazelaar C; Canters R; Peeters S; Petit S; van Elmpt W
    Radiother Oncol; 2021 Oct; 163():136-142. PubMed ID: 34461185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of [18F]fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non-small-cell lung cancer: a prospective study.
    Kolodziejczyk M; Kepka L; Dziuk M; Zawadzka A; Szalus N; Gizewska A; Bujko K
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1008-14. PubMed ID: 20656419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
    Gillham C; Zips D; Pönisch F; Evers C; Enghardt W; Abolmaali N; Zöphel K; Appold S; Hölscher T; Steinbach J; Kotzerke J; Herrmann T; Baumann M
    Radiother Oncol; 2008 Sep; 88(3):335-41. PubMed ID: 18514339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer.
    Schwarz M; Alber M; Lebesque JV; Mijnheer BJ; Damen EM
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):561-70. PubMed ID: 15890601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined PET/CT for IMRT treatment planning of NSCLC: contrast-enhanced CT images for Monte Carlo dose calculation.
    Mönnich D; Lächelt S; Beyer T; Werner MK; Thorwarth D
    Phys Med; 2013 Nov; 29(6):644-9. PubMed ID: 22975430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variations in the contouring of organs at risk: test case from a patient with oropharyngeal cancer.
    Nelms BE; Tomé WA; Robinson G; Wheeler J
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):368-78. PubMed ID: 21123004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC).
    Greco C; Rosenzweig K; Cascini GL; Tamburrini O
    Lung Cancer; 2007 Aug; 57(2):125-34. PubMed ID: 17478008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
    Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319.
    Vicini F; Winter K; Straube W; Wong J; Pass H; Rabinovitch R; Chafe S; Arthur D; Petersen I; McCormick B
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1531-7. PubMed ID: 16198508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.